**6. Conclusions**

There seem to be different ways to achieve the same final phenotype: LVNC. As genetic testing in LVNC has a good genetic yield and provides valuable information, it should be recommended for all LVNC patients. LVNC without an underlying genetic cause may have a better prognosis in terms of LVEF evolution in time. However, anticoagulation to prevent CVA should be carefully evaluated in all patients. Larger series with pathologic examination are needed to help better understand this entity.

**Supplementary Materials:** The following are available online at http://www.mdpi.com/2077-0383/9/8/2524/s1, Table S1: Overall coverage of the gene panel.

**Author Contributions:** Conceptualization, R.L., I.P., and J.J.R.R.; Data curation, M.M., E.C.-L., and J.G.; Formal analysis, R.L., H.C., and E.C.-L.; Funding acquisition, I.P.; Investigation, R.L., A.A., B.D.M., E.C., and J.G.; Methodology, M.M., I.P., A.A., and P.A.; Resources, C.M.; Software, H.C.; Supervision, M.M., I.P., J.J.R.R. and C.M.; Validation, A.A., B.D.M., E.C., and J.G.; Writing—original draft, R.L.; Writing—review & editing, R.L., M.M., P.A., J.J.R.R., and J.G. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.
